Bronchoscopic lung volume reduction with one-way endobronchial valves (EBVs) in patients with severe hyperinflation and emphysema has been shown to significantly improve lung function, quality of life, and exercise capacity (1, 2). With this therapy, the most diseased lobe is occluded with EBVs to induce a lobar atelectasis, thus reducing hyperinflation. Using quantitative computed tomography (CT) scan